Stockreport

Asgard Therapeutics announces €30 million Series A financing to advance its first-in-class in vivo cell reprogramming platform for immuno-oncology [Yahoo! Finance]

Iron Mountain Incorporated (Delaware)Common Stock REIT  (IRM) 
Last iron mountain incorporated (delaware)common stock reit earnings: 2/13 06:00 am Check Earnings Report
PDF Lead program is AT-108, a first-in-class, off-the-shelf intra-tumoral therapy that leads to personalized and potent anti-cancer immune responses Expanding R&D team to [Read more]